Natera

Strategic Account Manager (US - West Coast)

Los Angeles, California, United States

Not SpecifiedCompensation
Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level
Full TimeJob Type
UnknownVisa
Artificial Intelligence, SaaS, BiotechnologyIndustries

Requirements

Candidates must have over 5 years of experience in Large Enterprise B2B account management or Business Development, ideally within the technology/SaaS sector. A strong understanding of SaaS sales cycles, customer lifecycle management, and account-based marketing strategies is required. High intellectual curiosity and research skills are preferred. Experience working with FTSE 100 and Fortune 500 companies is a plus.

Responsibilities

The Strategic Account Manager will drive revenue growth and build client relationships with Large Enterprise accounts, managing a portfolio of global customers. This role involves engaging with senior executives and C-Suite contacts, scaling technology usage within large organizations, and collaborating with Customer Success, Sales, Marketing, and Product teams. Responsibilities include conducting business reviews, maintaining CRM records, and achieving usage and revenue metrics.

Skills

Account Management
Revenue Growth
Client Relationship Management
AI Solutions
SaaS
Sales
Business Development
Strategic Planning

Natera

Genetic testing and diagnostics solutions provider

About Natera

Natera focuses on genetic testing and diagnostics, providing advanced solutions for cancer patients, transplant patients, and individuals assessing hereditary health risks. Their main technology is cell-free DNA (cfDNA) testing, which analyzes DNA fragments in the blood to detect minimal traces of cancer and assess organ health. Natera stands out by offering specialized tests like the Signatera ctDNA test and Panorama NIPT, along with genetic counseling services. The company's goal is to improve patient care and health outcomes through accurate genetic testing.

Austin, TexasHeadquarters
2004Year Founded
$149.9MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
1,001-5,000Employees

Benefits

Flexible medical plans
Investment options
Time off
Workplace perks

Risks

Hindenburg report accuses Natera of deceptive sales practices, risking legal challenges.
New Prospera Heart features may face slow adoption by healthcare providers.
Fetal RhD NIPT demand may drop post-RhIg shortage, affecting future sales.

Differentiation

Natera's Signatera test offers personalized ctDNA analysis for cancer patients.
Prospera Heart test uses unique Donor Quantity Score for transplant rejection detection.
Panorama NIPT test is a leader in non-invasive prenatal testing with 2 million tests.

Upsides

Increased adoption of liquid biopsy techniques boosts demand for Natera's cfDNA tests.
AI integration enhances accuracy and speed of Natera's cfDNA analysis.
Growing personalized medicine trend aligns with Natera's customized genetic tests.

Land your dream remote job 3x faster with AI